The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnimalcare Grp Regulatory News (ANCR)

Share Price Information for Animalcare Grp (ANCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 231.00
Bid: 224.00
Ask: 238.00
Change: 1.00 (0.43%)
Spread: 14.00 (6.25%)
Open: 230.00
High: 231.00
Low: 230.00
Prev. Close: 230.00
ANCR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Non-Executive Director

10 Feb 2022 14:46

RNS Number : 3425B
Animalcare Group PLC
10 February 2022
 

ANIMALCARE GROUP PLC

 

(the "Company" or the "Group")

 

Appointment of Non-Executive Director

 

10 February 2022. Animalcare Group plc (AIM: ANCR), the international animal health business, today announces the appointment of Dr Douglas Hutchens to its Board of Directors as an Independent Non-Executive Director with immediate effect.

 

Douglas Hutchens has held several senior positions in research and development (R&D) and regulatory affairs at leading global animal health companies. As part of the executive team at Bayer Animal Health, he was an Executive Vice President and Chief Veterinary Officer where he led both drug discovery and product development on a global basis. More recently, he has held positions on several R&D advisory boards.

 

Before joining the animal health pharmaceutical industry, Douglas was an Assistant Professor at the University of Illinois College of Veterinary Medicine. There, he conducted studies for most of the major animal health companies and participated in the development of multiple new products for companion and production animals. Early in his career he was a practicing veterinarian. Douglas holds a Doctor of Veterinary Medicine degree and a PhD in pathobiology with an emphasis in immuno-parasitology from the University of Illinois.

 

Jan Boone, Chairman of Animalcare Group plc, said: "We are delighted to welcome Douglas to the Animalcare Group Board. Douglas brings a wealth of expertise in veterinary medicine and R&D from leadership roles at some of the world's biggest animal health companies. His knowledge and extensive network will prove invaluable as we pursue our long-term growth strategy."

 

Additional Information

 

The following information is disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Douglas Eugene Hutchens, aged 58:

 

Current Directorships

Previous Directorships

None

Bayer Animal Health GmbH

As of the date of this announcement, Dr Hutchens holds no ordinary shares in the capital of the Company. Save as disclosed above there are no additional disclosures to be made in accordance with Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies.

 

Enquiries

 

Animalcare Group plc

Jenny Winter, Chief Executive Officer

Chris Brewster, Chief Financial Officer

Media/investor relations

 

+44 (0)1904 487 687

 

 

communications@animalcaregroup.com

 

Stifel Nicolaus Europe Limited(Nominated Adviser & Joint Broker)

Ben Maddison

Fred Walsh

Nicholas Harland

Nick Adams

 

+44 (0)20 7710 7600

Panmure Gordon

(Joint Broker)

Corporate Finance

Freddy Crossley/Emma Earl

Corporate Broking

Rupert Dearden

 

+44 (0)20 7886 2500

 

About Animalcare

Animalcare Group plc is a UK AIM-listed international veterinary sales and marketing organisation. Animalcare operates in seven countries and exports to approximately 40 countries in Europe and worldwide. The Group is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.

 

For more information about Animalcare, please visit www.animalcaregroup.com 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADZGMZDGDGZZM
Date   Source Headline
15th Mar 20138:15 amRNSChange of Registered Office
4th Mar 20131:10 pmRNSHolding(s) in Company
21st Feb 20131:00 pmRNSGrant of Share Options
21st Feb 20137:00 amRNSHalf Yearly Report
11th Jan 20137:00 amRNSDirectorate Change
11th Jan 20137:00 amRNSPost-Close Trading Update & Notice of Results
3rd Jan 20137:00 amRNSSale of Buprecare ampoules resumed
21st Dec 20125:55 pmRNSDirector/PDMR Shareholding
19th Dec 20128:39 amRNSShare Allotment and Total Voting Rights
21st Nov 20126:30 pmRNSGrant of Share Options
6th Nov 20124:47 pmRNSResult of AGM
6th Nov 20127:00 amRNSAGM Statement
29th Oct 20127:00 amRNSChange of Name of Adviser
12th Oct 20129:15 amRNSAnnual Report and Notice of Annual General Meeting
5th Oct 20121:44 pmRNSHolding(s) in Company
4th Oct 20127:00 amRNSFinal Results
4th Oct 20127:00 amRNSGranting of a Marketing Authorisation
6th Sep 20127:00 amRNSLaunch of New Veterinary Medicine
3rd Aug 20121:51 pmRNSGrant of Share Options
11th Jul 20127:00 amRNSPre-Close Trading Update
25th Jun 201210:05 amRNSReplacement re Grant of Share Options
25th Jun 20127:00 amRNSGrant of Share Options
24th May 20127:00 amRNSTrading update
1st May 20126:11 pmRNSShare Allotment and Total Voting Rights
30th Mar 20126:09 pmRNSTotal Voting Rights
28th Mar 20125:02 pmRNSHolding(s) in Company
23rd Mar 20127:00 amRNSMarketing Authorisation for Project Quattro
12th Mar 20127:00 amRNSDirectorate Change
1st Mar 20125:09 pmRNSReplacement re Share Allotment, Director S/hldg
27th Feb 20125:21 pmRNSShare Allotment, Director Shareholdings & TVR
20th Feb 20127:00 amRNSHalf Yearly Report
1st Feb 20127:00 amRNSChange of Adviser
26th Jan 20127:00 amRNSDirectorate Change
26th Jan 20127:00 amRNSPost-Close Trading Update & Notice of Results
4th Jan 201210:23 amRNSHolding(s) in Company
25th Nov 20115:12 pmRNSHolding(s) in Company
11th Nov 20117:00 amRNSDirectorate Change
4th Nov 20111:55 pmRNSGrants of Share Options to Directors
4th Nov 20111:51 pmRNSHolding(s) in Company
31st Oct 201112:00 pmRNSTotal Voting Rights
28th Oct 20117:00 amRNSAGM Statement
10th Oct 20115:04 pmRNSShare Allotment & Director Shareholdings
6th Oct 20117:00 amRNSAnnual Report and Notice of Annual General Meeting
4th Oct 20114:17 pmRNSHolding(s) in Company
4th Oct 20113:07 pmRNSShare Allotment & Director Shareholdings
30th Sep 201112:17 pmRNSTotal Voting Rights
19th Sep 20117:00 amRNSFinal Results
9th Sep 20113:09 pmRNSShare Allotment
2nd Sep 20112:45 pmRNSChange of Registered Office
1st Sep 20112:25 pmRNSShare Allotment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.